|
|
Article: QBI Buys Microarray Goods Plus Personnel From Incyte.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
West Coast Editor
Quark Biotech Inc. paid an undisclosed sum for the microarray facilities and personnel of Incyte Genomics Inc., thereby beefing the former's profiling and chemical screening capabilities and completing another piece of the latter's restructuring.
"We were for many years one of their major customers, and we were the first customer of Synteni [Inc., of Fremont, Calif., which Incyte took over for $80 million in late 1997]," said Daniel Zurr, founder and CEO of privately held QBI.
"It's kind of closing the circle," he said.
QBI, of Cleveland, has hired the management and key personnel that operated the Incyte facility in ...
Related newspaper, magazine, and journal articles:
|